Skip to main content
Supplement ScienceSupplementScience

Resveratrol Research & Evidence

·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence Level

Moderate

Resveratrol is a polyphenolic compound that has garnered significant attention for its potential health benefits. Thousands of studies have investigated its effects on longevity and various health conditions, though its role in extending lifespan remains debated. Early research by Baur et al. (2006) demonstrated resveratrol's ability to extend the lifespan of mice on high-fat diets through activation of SIRT1, a protein associated with aging and metabolism.

A meta-analysis by Liu et al. (2014) confirmed resveratrol's metabolic benefits in diabetic patients, showing improvements in glucose control and insulin sensitivity across 11 randomized controlled trials (RCTs). However, challenges with bioavailability persist, as less than 1% of orally administered resveratrol reaches systemic circulation unchanged due to rapid glucuronidation and sulfation. Despite this, metabolite activity has been implicated in some observed benefits.

Recent systematic reviews and meta-analyses have provided further insights into resveratrol's effects. Lahouti et al. (2025) found that resveratrol supplementation significantly reduced body weight, BMI, and waist circumference in patients with type 2 diabetes, based on a meta-analysis of 11 RCTs involving 614 participants. Conversely, Rodrigues Uggioni et al. (2025) reported no significant effects of resveratrol on lipid profiles in postmenopausal women after reviewing two clinical trials.

Resveratrol has also shown promise in other areas. Damay and Ivan (2024) found that it significantly reduced TNF-α levels in individuals at risk for coronary artery disease, particularly at a dose of 15 mg per day. Additionally, Larik et al. (2024) demonstrated that resveratrol improved prolactin levels, acne scores, and total cholesterol in women with polycystic ovary syndrome (PCOS), based on three RCTs involving 169 participants.

Despite these findings, the directness of resveratrol's activation mechanism for SIRT1 has been debated since David Sinclair's landmark work. While initial enthusiasm was high, subsequent studies have tempered expectations regarding its role in longevity and other health outcomes.

Evidence by Condition

ConditionStudied DoseEvidence
General longevity / sirtuin activation150-500mg dailyEmerging
Glucose metabolism150-250mg dailyModerate
Cardiovascular support250-500mg dailyEmerging

Related Research Summaries

References

  1. RCTTimmers S, Konings E, de Vogel-van den Bosch J, et al. (2011). Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metabolism. DOI PubMed
  2. Meta-analysisRodrigues Uggioni ML, Ronsani L, Motta S, Denoni Júnior JC, et al. (2025). Effects of resveratrol on the lipid profile of post-menopause women: Systematic review and meta-analysis.. Nutrition, metabolism, and cardiovascular diseases : NMCD. DOI PubMed
  3. Meta-analysisLahouti M, Arzhang P, Azadbakht L (2025). A Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Impact of Resveratrol Supplementation on Anthropometric Indices in Patients With Type 2 Diabetes.. Phytotherapy research : PTR. DOI PubMed
  4. Meta-analysisDamay VA, Ivan I (2024). Resveratrol as an Anti-inflammatory Agent in Coronary Artery Disease: A Systematic Review, Meta-Analysis and Meta-Regression.. Chinese journal of integrative medicine. DOI PubMed
  5. Meta-analysisLarik MO, Ahmed A, Khan L, Iftekhar MA (2024). Effects of resveratrol on polycystic ovarian syndrome: a systematic review and meta-analysis of randomized controlled trials.. Endocrine. DOI PubMed
  6. Meta-analysisAlam MK, Alqhtani NR, Alnufaiy B, Alqahtani AS, et al. (2024). A systematic review and meta-analysis of the impact of resveratrol on oral cancer: potential therapeutic implications.. BMC oral health. DOI PubMed
  7. Meta-analysisMolani-Gol R, Rafraf M (2024). Effects of resveratrol on the anthropometric indices and inflammatory markers: an umbrella meta-analysis.. European journal of nutrition. DOI PubMed
Show 3 more references
  1. Meta-analysisLiu X, Gu X, Zhang J, Li X, et al. (2024). Resveratrol delays the progression of diabetic nephropathy through multiple pathways: A dose-response meta-analysis based on animal models.. Journal of diabetes. DOI PubMed
  2. Meta-analysisAli Fadlalmola H, Elhusein AM, Al-Sayaghi KM, Albadrani MS, et al. (2023). Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.. The Pan African medical journal. DOI PubMed
  3. Meta-analysisLuís Â, Marcelino H, Domingues F, Pereira L, et al. (2023). Therapeutic Potential of Resveratrol for Glioma: A Systematic Review and Meta-Analysis of Animal Model Studies.. International journal of molecular sciences. DOI PubMed